These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2186609)

  • 21. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The myocardial renin-angiotensin system: existence, importance, and clinical implications.
    Grinstead WC; Young JB
    Am Heart J; 1992 Apr; 123(4 Pt 1):1039-45. PubMed ID: 1549968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of angiotensin-converting enzyme inhibition on cardiac function in myocardial infarction.
    Ertl G; Gaudron P; Kochsiek K
    Am J Cardiol; 1990 Apr; 65(14):70G-73G. PubMed ID: 2181851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart.
    Traquandi C; Riva E
    Pharmacol Res; 1998 Jan; 37(1):57-65. PubMed ID: 9503481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.
    Przyklenk K; Kloner RA
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):167S-175S. PubMed ID: 2690907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of angiotensin-converting enzyme inhibitors after acute myocardial infarction.
    Mehra IV; Wilson MD
    Pharmacotherapy; 1993; 13(5):440-6. PubMed ID: 8247909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ischemic effects of angiotensin-converting enzyme inhibitors: a future therapeutic perspective.
    Ambrosioni E; Bacchelli S; Esposti DD; Borghi C
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S3-9. PubMed ID: 11392476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac renin-angiotensin system. Molecular and functional aspects.
    Dzau VJ
    Am J Med; 1988 Mar; 84(3A):22-7. PubMed ID: 3218653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.